Skip to main content
Premium Trial:

Request an Annual Quote

PopGenTech and Quintiles Partner to Apply Large-Scale Sequencing to Drug Development

Premium

UK-based startup Population Genetics Technologies and biopharmaceutical services company Quintiles are collaborating to offer large-scale genomic analyses for clinical trials.

Under the non-exclusive collaboration, the partners will "jointly identify opportunities" to apply genomic analyses in hundreds to thousands of samples to test clinical hypotheses and to correlate biomarkers of disease prognosis and drug response.

PopGenTech will use its technology, a recently published tagging method that allows it to sequence pools of samples and distinguish between true variants and errors introduced during sample prep (IS 5/10/2011).

The companies' first project will be a renal cancer clinical trial for an undisclosed Quintiles client. The partners aim to identify genetic markers that are predictive of adverse events and efficacy.

"PGT's technology combined with Quintiles' global presence can bring the benefits of large-scale sequencing and analysis to virtually all biopharmaceutical companies," said King Jolly, senior vice president of Quintiles Innovation, in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.